Boston Scientific (BSX) May option implied volatility into quarter results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall St indexes fall to two-week lows as rising bond yields, disappointing Walmart results drag
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Deutsche Bank calls Treasury buyback doubling similar to ’operation twist’
Boston Scientific (BSX) PT Raised to $77 at Oppenheimer
April 25, 2024 10:00 AM EDTOppenheimer analyst Steven Lichtman raised the price target on Boston Scientific (NYSE: BSX) to $77.00 (from $68.00) while maintaining a Outperform rating.
The analyst comments "BSX delivered 1Q24 sales meaningfully ahead of the Street (13% organic y/y). EPS was also beat ($0.56 versus our/Street's... More
Boston Scientific (BSX) PT Raised to $82 at Wells Fargo
April 25, 2024 5:23 AM EDTWells Fargo analyst Lawrence Biegelsen raised the price target on Boston Scientific (NYSE: BSX) to $82.00 (from $72.00) while maintaining a Overweight rating.
The analyst comments "Today (4/24), BSX reported Q1 rev/EPS ahead of Street and raised 2024 rev guidance by 250bps at the mdpt to 10-12%.... More
Boston Scientific (BSX) PT Raised to $80 at BTIG
April 24, 2024 3:14 PM EDTBTIG analyst Marie Thibault raised the price target on Boston Scientific (NYSE: BSX) to $80.00 (from $74.00) while maintaining a Buy rating.
The analyst comments "After a record-setting 2023, Boston Scientific is starting 2024 at an even faster pace. BSX reported Q1 revenue of $3.856B (+13.8% y/y rep., +13.1% org.) and adj. EPS of $0.56 (consensus $3.684B and $0.51), well above its guidance... More

